← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Decimmune Therapeutics, Inc
Cambridge, MA
$5,251,385
Total funding
4
Grants
Funding over time
peak $2M · FY2006–14$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,251,385 · 4
By mechanism
R44$4,993,073 · 2
R43$258,312 · 2
Investigators at Decimmune Therapeutics, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Therapeutic to Reduce Acute Inflammation Following Cardiac Ischemia$1,119,082
R44 · FY2010 · HL
Therapeutic to Reduce Acute Inflammation Following Cardiac Ischemia$1,044,768
R44 · FY2011 · HL
Humanized Antibody Therapeutic to Improve Cardiac Function Following Myocardial I$999,700
R44 · FY2014 · HL
Therapeutic to Reduce Acute Inflammation in Severe Burn Injuries$916,032
R44 · FY2009 · GM
Therapeutic to Reduce Acute Inflammation in Severe Burn Injuries$913,491
R44 · FY2010 · GM
Therapeutic to Reduce Acute Inflammation Following Cardiac Ischemia$129,156
R43 · FY2006 · HL
Therapeutic to Reduce Acute Inflammation in Severe Burn Injuries$129,156
R43 · FY2006 · GM